Search Result Details

This page shows the details of why an item matched the keywords from your search.
One or more keywords matched the following properties of Strange, Charlie
overview Dr. Charlie Strange is a Professor of Pulmonary and Critical Care Medicine at MUSC with faculty appointments in the Department of Medicine and the Department of Graduate Studies. His clinical interests include chronic obstructive pulmonary disease (with specialty interest in alpha-1 antitrypsin deficiency and bronchoscopic lung volume reduction) and interstitial lung disease (with specialty interest in the connective tissue diseases). Dr. Strange has interest in rare lung diseases and participates in NIH programs to advance their treatment. He is the Principal Investigator for the Alpha-1 Foundation Research Registry, the largest registry of individuals with alpha-1 antitrypsin deficiency or the carrier state in the world. The Registry is used to support research on new therapies, genetic linkage studies, and social sciences research. The Alpha Coded Testing (ACT) study provides confidential testing for alpha-1 antitrypsin deficiency. Dr. Strange is available for physician consultations on the above research studies and continues active inpatient and outpatient clinical service. For this activity and teaching he has been listed in “Best Doctors in America” 2003-2015 for General Pulmonary and Critical Care Medicine, Interstitial Lung Diseases, and Chronic Obstructive Pulmonary Disease.
One or more keywords matched the following items that are connected to Strange, Charlie
Item TypeName
Academic Article Aclidinium bromide plus formoterol for the treatment of chronic obstructive pulmonary disease.
Academic Article Gender and asthma-chronic obstructive pulmonary disease overlap syndrome.
Academic Article Characteristics and Prevalence of Asthma/Chronic Obstructive Pulmonary Disease Overlap in the United States.
Academic Article Targeting Persons With or At High Risk for Chronic Obstructive Pulmonary Disease by State-based Surveillance.
Academic Article Comparative effectiveness of budesonide/formoterol combination and fluticasone/salmeterol combination among chronic obstructive pulmonary disease patients new to controller treatment: a US administrative claims database study.
Academic Article Body mass index, respiratory conditions, asthma, and chronic obstructive pulmonary disease.
Academic Article Long-term effects of inhaled corticosteroids on FEV1 in patients with chronic obstructive pulmonary disease. A meta-analysis.
Academic Article Mortality in Asthma-Chronic Obstructive Pulmonary Disease Overlap in the United States.
Academic Article Evaluating fluticasone furoate + vilanterol for the treatment of chronic obstructive pulmonary disease (COPD).
Academic Article A Retrospective Claims Analysis of Dual Bronchodilator Fixed-Dose Combination Versus Bronchodilator Monotherapy in Patients with Chronic Obstructive Pulmonary Disease.
Academic Article Proactive Electronic Visits for Smoking Cessation and Chronic Obstructive Pulmonary Disease Screening in Primary Care: Randomized Controlled Trial of Feasibility, Acceptability, and Efficacy.
Search Criteria
  • Lung Diseases Obstructive